Colorectal Cancer Genomics
- Cancer PHGKB -
Last Posted: Nov 15, 2018
- Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.
Taniguchi Hiroya et al. Neoplasia (New York, N.Y.) 2018 Nov 20(12) 1219-1226
- Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients.
Fouad Mariam A et al. Frontiers in pharmacology 2018 91173
- Multiplex Cell-Free DNA Reference Materials for Quality Control of Next-Generation Sequencing-Based In Vitro Diagnostic Tests of Colorectal Cancer Tolerance.
Liu Donglai et al. Journal of Cancer 2018 9(20) 3812-3823
- A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report.
Iwahashi Naoyuki et al. Oncology letters 2018 Nov 16(5) 6431-6436
- MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To Kenneth Kw et al. World journal of gastroenterology 2018 Jul 24(27) 2949-2973
- Real world experience of BRAFV600E mutation specific immunohistochemistry in colorectal carcinoma.
Reagh Jessica et al. Pathology 2018 50(3) 342-344
- Lets Talk About Your DNA
Huntsman Cancer Institute, November 7, 2018
- Punctate MLH1 mismatch repair immunostaining in colorectal cancer.
Loughrey Maurice B et al. Histopathology 2018 Oct
- Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
Choi Yun-Hee et al. Journal of the National Cancer Institute 2018 Oct
- [Association between serotonin transporter promoter gene polymorphism and clinicopathological factors and effect of the polymorphism on the prognosis of colorectal cancer patients].
Luo Minrui et al. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2018 Jul 21(7) 814-818